Therefore, this finding suggests either that the mutant p53γ isoform has an intrinsic activity abrogating the poor prognosis associated with p53 mutation or that p53γ is just an inactive marker of better outcomes for mutant p53 breast cancer patients. Here, TP53 is linked to breast carcinoma.